US Patent 7351691 Glycopeptide phosphonate derivatives
Patent 7351691 was granted and assigned to Theravance on April, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Martin S. Linsell0
Michael R. Leadbetter0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+288 characters)
Article
Patent abstract
Disclosed are glycopeptides that are substituted with one or more substituents each comprising one or more phosphono groups; and pharmaceutical compositions containing such glycopeptide derivatives. The disclosed glycopeptide derivatives are useful as antibacterial agents.
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07351691 Glycopeptide phosphonate derivatives US Patent 7351691 Glycopeptide phosphonate derivatives
Infobox
Patent Number
073516910
Patent Number
73516910
Edits on 27 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073516910
Date of Patent
April 1, 2008
0Patent Application Number
115849080
Date Filed
October 23, 2006
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 24 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07351691 Glycopeptide phosphonate derivatives
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07351691
Date of patent
April 1, 2008
Patent application number
11584908
Date Filed
October 23, 2006
Patent primary examiner
Find more entities like US Patent 7351691 Glycopeptide phosphonate derivatives
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
